The development of multi-analyte methods for lipophilic shellfish toxins based on liquid chromatography-mass spectrometry permits rapid screening and analysis of samples for a wide variety of toxins in a single run. To ensure accuracy of results, validated methods and appropriate certified reference materials (CRMs) are required. CRMs are essential for accurate instrument calibration, for assessing the complete analytical method from sample extraction to data analysis, and for verifying trueness. However, CRMs have hitherto only been available for single toxin groups.
Introduction
Shellfish are valued as a nutritionally healthy food and are consumed in almost every part of the world. Increased demand in recent years has resulted in significant growth of the shellfish industry worldwide. If toxigenic algae bloom in a shellfish growing area, shellfish may become toxic. While few effects on the shellfish are usually observed, human consumption of shellfish contaminated with phycotoxins has led to numerous poisoning incidents [1] [2] [3] . This can also have major effects on the economy of the aquaculture industry. Comprehensive toxin monitoring programs are in place to protect human health and the toxin levels in shellfish tissues are regulated in most jurisdictions. For many years the mouse bioassay (MBA) [4] was the existing reference method for lipophilic shellfish toxins and it has been reasonably effective as a non-specific indicator of toxicity. However, there are numerous problems with testing on animals: ethical issues; lack of sensitivity resulting in false negatives; lack of specificity which can lead to false positives; inability to distinguish between different toxins groups; unsuitable for multi-toxin detection; and lack of internationally accepted validation. The need for alternative and validated methods is therefore widely accepted [5] . Consequently, much research has gone into development of chemical analytical methods for monitoring [6] [7] [8] [9] [10] . As there are various toxin groups regulated, it is desirable to have multi-toxin methods. As a result, procedures based on liquid-chromatography coupled with mass-spectrometry (LC-MS) are rapidly becoming the methods of choice [11] [12] [13] [14] .
Alternative methods to the MBA can only be implemented once they are validated and accurately calibrated. Reference materials (RMs) are necessary for such operations and to fulfil the quality control requirements of official testing laboratories. [15] [16] [17] [18] . Unfortunately the limited availability of shellfish toxin RMs has restricted progress in development and validation of alternative methods.
Some work has been done the production of RMs for shellfish toxins [19] [20] [21] , however, these materials were not certified or widely available. Since the domoic acid (DA) poisoning event [22] the National Research Council's CRM Program (CRMP) has produced a number of phycotoxin CRMs [23] . Calibrant CRMs are currently available for DA, okadaic acid and dinophysistoxins (OA & DTXs), azaspiracids (AZAs), yessotoxin (YTX), pectenotoxins (PTX2), spirolides (13-desMe-C SPX) and a range of paralytic shellfish poisoning (PSP) toxins [24] . Along with calibrants it is necessary to have matrix CRMs that comprise the analyte(s) of interest present in their natural form, and in their natural environment. These test and validate each step of an analytical method. CRMP distributes mussel (Mytilus edulis) matrix CRMs for DA and OA/DTX groups. However, a multi-toxin matrix CRM is a necessity for development and validation of multi-toxin methods.
A collaborative project was commenced with the aim of producing and certifying a candidate matrix CRM for multiple groups of lipophilic shellfish toxins. Collaborators provided contaminated tissues, algal pastes, purified/semi-purified toxins, or contributed expertise in the preparation and characterisation work. The major toxin groups and analogs represented in the candidate CRM are shown in Fig. 1 .
In order for RMs/CRMs to be fit for purpose they must satisfy the requirements of homogeneity and stability. Additionally they must be representative of samples analysed on a day-to-day basis in testing laboratories. Mussel (Mytilus edulis) was chosen as the matrix for the candidate CRM as this is a commonly distributed shellfish species and mussels frequently accumulate phycotoxins to high levels. From the point of view of homogeneity and stability it must be ensured that all steps involved in the handling and processing of the material, up until final bottling and storage, facilitate these requirements [18] . Stabilisation of a multi-toxin material presented a significant challenge due to the variety of groups of toxins present, each with different stabilities and susceptibilities under varying conditions. Heat treatment has been investigated for DA and OA group toxins [25, 26] and thermal sterilisation was used for stabilization of matrix CRMs containing these toxins [27, 28] . However, this method is inappropriate for the AZAs [29] . A feasibility study on gamma-irradiation showed that it was suitable for various toxin groups [30] . However, long-term stability information is not available for this treatment for many of the toxin of interest in this project. The simple use of stabilisers has proven to be an efficient way of maintaining the stability of mussel tissue RMs or DA [31] . However, limited data is available on the effectiveness of additives for stabilization of lipophilics toxins. Drying is a common stabilisation method for biological matrix RMs [32] , with freeze-drying particularly suitable for heat sensitive compounds thanks to the gentle manner of the process. A feasibility study showed that freeze-drying was very effective for a variety of toxins [33] . No degradation of DA was observed over a 9-month period at temperatures up to 40°C, while degradation was observed in an equivalent wet homogeneate after only a number of days. Improved stability was also observed for lipophilic analytes. Taking all the available information into account and considering the value of the toxin materials used, it was decided that in order to ensure optimum stability of the multi-toxin material would be prepared as a freeze-dried mussel powder. This paper outlines extensive work done in characterisation of the raw materials, design and preparation of a bulk wet homogenate, freeze-drying the wet material, production of an homogenous powder, and finally bottling of the candidate CRM. Toxin concentrations of the constituent wet tissues are shown, the physical characterisation of the freeze-dried powder is described, and an indicative concentration profile of the candidate CRM is given.
Experimental

standards and Chemicals
Methanol, ethanol and acetonitrile were obtained as pesticide grade solvents (Pestican®) (Labscan, Dublin, Ireland). A reverse osmosis purification system supplied water for the mobile phase (Barnstead International, Dubuque, IA, USA). Formic acid, ammonium formate, trifluoroacetic acid, ethoxyquin, oxytetracycline, ampicillin and erythromycin were obtained from Sigma-Aldrich (St. Louis, MO, USA).
DA, OA, PTX2 and 13-desMe-SPX-C calibration standards were prepared from certified calibration solutions (NRC-IMB, CRMP, Halifax, NS, Canada: CRM-DA-d, CRM-OA, CRM-PTX2, CRM-SPX1). The OA standard was used for quantitation of DTX1 and DTX2 assuming equi-molar response factors. AZA1 isolated under supervision of Dr. M. Satake [Hess P (2001) Marine Institute, unpublished internal report] was used for calibration of AZA1, AZA2 and AZA3, assuming equi-molar response factors.
Collation and Processing of mussel (Mytilus edulis) tissues (marine Institute)
2.2.1. Material A (Canadian mussel whole flesh containing DA) Mussels containing high levels of DA were obtained in Cardigan Bay, Eastern Prince Edward Island (Canada, December 1987). After harvesting they were steam cooked for 10 min, shucked and placed in long-term freezer storage (-20°C). For the CRM production 5 kg of these mussels were shipped to the Marine Institute.
Significant desiccation of the material had occurred during storage so 2 kg of water was added to 4 kg of the whole flesh and this was mixed using a Waring blender (Hartford, CT, USA). To further homogenize a Polytron (PT6100, Kinematica, Lucerne, Switzerland) was used. To inactivate enzymes the homogenate was autoclaved at 121°C for 15 min (Touchclave LAB K200E, Davidson & Hardy Ltd., Dublin, Ireland). After autoclaving the material was re-homogenized using the Polytron with coarse grade followed by fine grade dispersing aggregates. Byssus and shell debris were removed at this stage. Approximately 11 kg of hepatopancreas tissues were dissected using scalpels and then autoclaved (conditions as above). After autoclaving, de-ionised water (750 mL) was added to 10.75 kg of the tissue. This was homogenized in 2 kg lots using a Waring blender and then the Polytron. All the hepatopancreas material was then combined in a 27 L bucket and blended using a Silverson DX batch homogeniser (Silverson Ltd., Bucks, UK).
2.2.3. Material C (Castletownbere remainder tissues containing OA, DTX2 and AZAs) Mussels contaminated with OA, DTX2 and AZAs were retrieved from Castletownbere (Bantry Bay, Southwest Ireland, 2001). The hepatopancreas of these mussels had been removed for use in toxin isolation work [34] leaving bulk quantities of remainder tissues in storage (-20°C). As a significant quantity of hepatopancreas tissues were being used from the Norwegian tissues (Material B) it was desirable to use some remainder tissues to maintain a 'typical' whole flesh balance for the candidate CRM.
The tissue was autoclaved to eliminate enzymatic activity. Although it had been homogenized after dissection of the hepatopancreas it was necessary to re-homogenise to ensure representative sub-sampling of the bulk for toxin characterisation. Approximately 35 kg of the remainder material was blended and homogenized using the Waring blender, followed by the Polytron, and finally with the Silverson mixer. Prior to the Polytron step 6 kg of de-ionized water was added to the bulk to improve fluidity.
Material D (Bruckless mussel whole flesh containing AZAs)
Mussels with high levels of AZAs were collected from the Northwest Irish coast (McSwyne's Bay, Bruckless, Co. Donegal, September 2005). After harvesting the mussels were steam cooked for 12.5 min, removed from the shell, and vacuum packed in 1 kg bags for storage (-20°C).
After removal of byssus and shell debris 18.5 kg of the whole flesh was autoclaved. Autoclaving also serves to stabilise the AZA toxin profile in naturally contaminated tissues [35] . The material was processed with a Waring blender (3 kg portions), adding 5.5 kg of de-ionized water in total to achieve the required consistency. The portions were further homogenized using a Polytron, before combining for final mixing with the Silverson homogeniser.
2.2.5. Material E (Ardgroom whole flesh containing OA and DTX2) Mussels contaminated with OA and DTX2 were harvested from the Southwest of Ireland (Ardgroom, Kenmare Bay, Co. Kerry, 2004). The shellfish were steam cooked for 10 min after harvesting, shucked, and vacuum packed in 1 kg portions for storage (-20°C).
The mussels were processed in the same way as material D (cleaning, autoclaving, addition of water, blending, homogenizing). In total, 55 kg of homogenate was prepared from the Ardgroom mussels.
Non mussel tissue materials
Purified yessotoxin
A sample (58 mg) of purified yessotoxin prepared as the disodium salt from an algal culture [36] was stored in MeOH in 6 vials at -20 °C. The material was evaporated to dryness under nitrogen for shipping, and then transferred with MeOH (6 × 0.5 mL rinses per vial) to a 50 mL volumetric flask that was made up to volume with MeOH.
Alexandrium ostenfeldii pellet
Eight centrifuge tubes containing Alexandrium ostenfeldii biomass from a culture established from isolates from Ship Harbour, Nova Scotia, Canada were stored frozen. This culture contained a number of SPXs [37] , most significantly 13-desMe-C SPX. After defrosting, 10 mL of MeOH was added to each tube and then vortex mixed for a few seconds. The content of the tubes were then transferred to a flask. This process was repeated 3 times for each tube to retrieve the entire pellet. The flask containing the combined biomass was made up to 500 g with MeOH.
Dinophysis spp. extract containing PTX2
An ethereal extract produced during purification of material collected from natural populations of Dinophysis spp. in Spain and Norway [38] was evaporated to dryness under nitrogen to form a paste (approximately 40 g) containing PTX2 (approximately 15 mg). The material was shipped in four tubes, the contents of which were transferred to a pre-weighed 250 mL volumetric flask (with MeOH 3 × 10 mL per tube) and the flask was made up to volume with MeOH.
Toxin determination
DA extraction and analysis
Samples (4 g) of the processed materials were extracted twice using 16 mL volumes of 50% aqueous MeOH and made up to 50 mL. Aliquots of the combined phases made up to volume were filtered through 0.2 μm filters (Schleicher & Schuell, Whatman, Brentford, UK) into HPLC vials for analysis. DA was determined as the sum of DA and epi-DA, closely following the procedure published by Quilliam et al. [39] with some minor modifications [40] . A Shimadzu HPLC system with a photodiode array (PDA) detector was used (Shimadzu Inc., Kyoto, Japan). A Vydac column (250 mm×4.6 mm) packed with 5 µm 201TP C 18 silica, was eluted isocratically with 9% acetonitrile in water with 0.1% trifluoroacetic acid. The column flush was flushed with 90% acetonitrile at the end of each run.
Lipophilic toxin extraction and analysis (OA and AZA groups)
Aliquots (2 g) of the processed materials were extracted twice with 9 mL volumes of 100% MeOH. Extracts were combined in 25 mL volumetric flasks and made up to the mark with extraction solvent [30] . OA group esters were determined using the base hydrolysis method [41] . Extracts were passed through 0.2 μm filters into HPLC vials for analysis.
Analysis was performed by LC-MS/MS using a 2695 Waters HPLC coupled to a triple stage quadrupole (Quattro Ultima, Micromass, Dublin, Ireland) equipped with a z-spray ESI source. A multi-toxin method was adapted from Quilliam et al. [11] . A binary mobile phase was used, with A (100% aqueous) and B (95% acetonitrile) each containing 2 mM ammonium formate and 50 mM formic acid. A gradient was run at 250 µL/min on a 50 mm × 2 mm i.d., 3 μm BDS-Hypersil C8 column (Thermo Fisher Scientific, Loughborough, U.K.) with a 10 mm × 2 mm guard column. Starting with 30% B at time zero, B was raised to 90% at 8 min. Then, the 90% B was held for 2.5 min, decreased to 30% B over 0.5 min and was held again for 3 min until the next run. Analyses were conducted using MRM mode (OA/DTX2 : m/z 842.5>672.5, 856.5>672.5, 828.5>658.5, respectively. With this method OA and the DTXs eluted first (ca. 6.5 -8 min), followed by the AZAs (ca. 10-12 min).
Analysis of non-tissue materials
For analysis of PTX2 in the Dinophysis spp. extract, a dilution in MeOH was prepared and the LC-MS method used for OA and AZA was applied using [M+H] + m/z 876.5>823.5 as the quantitative PTX2 transition.
A sample of the Alexandrium ostenfeldii pellet was extracted by sonicating in MeOH. 13-desMe-C SPX was analysed on an Acquity UPLC (Waters Inc., Dublin, Ireland) coupled to a Micromass Q-ToF Ultima (quadrupole-time-of flight hybrid) (Dublin, Ireland). The binary mobile phase described for the lipophilic toxins was used with an Acquity UPLC BEH C18 column (2.1  100 mm i.d., 1.7 µm) running a gradient at 400 µL/min from 30% to 90% B over 3 min, and then holding for 1.5 min before re-equilibrating. The Q-ToF was operated in ToF-MS-MS mode doing quantitation on m/z 692.
The purified YTX material had been quantified at AgResearch prior to receipt at the Marine Institute.
Moisture content analysis
Aliquots of tissue (1 -2 g) were weighed into the pre-weighed centrifuge tubes. The tubes were then placed in a Jouan RC10.22 rotary drier (Jouan, Saint Herblain, France), dried under vacuum (optimized conditions: 950 min run, #4 heat setting, Pulse vent "OFF"), and the mass retaken after cooling to determine moisture content by loss.
Combination of materials and Bulk homogenization (marine Institute)
Following characterisation of the individual tissue materials, the quantities required for an appropriate toxin profile in the candidate CRM were decided upon. Due to the scale of the preparation (>100 kg), a homogenization procedure was designed so that it would begin with the smallest quantities of tissues in small vessels, and move to increasingly larger vessels as the bulk increased, until finally all the separate materials and required water were combined.
Procedure
Material A (5.5 kg) was mixed in a 10 L bucket with a solution containing a combination of additives (30 g each of ethoxyquin, ampicillin, oxytetracycline and erythromycin in 800 g of ethanol). The YTX, PTX2 and Alexandrium ostenfeldii solutions were added at this stage, and each container was rinsed with 100 mL of ethanol, followed by 100 mL of water, to ensure complete transfer. The contents of the bucket were homogenized thoroughly using the Polytron (fine dispersing aggregate at 5000 rpm for 13 min; coarse dispersing aggregate at 3500 rpm for 10 min).
This combined material was transferred to a 27 L bucket, rinsing with 500 g of water.
Material B was added (11.2 kg) and homogenized using the Silverson mixer for 15 min. This homogenate was then transferred to a 210 L drum rinsing the 27 L bucket carefully with 1 L of water. Approximately 20 kg of material D was added and the contents of the drum were homogenized using the Silverson mixer for 30 min.
Next 29 kg of the material C was added, along with 10 kg of water for adjusting the moisture content of the final bulk homogenate. The combined materials were homogenized for 35 min using the Silverson blender.
Lastly 52 kg of material E was added. The Silverson mixer was in operation at a slow speed while these tissues were being added. The contents of the drum were then mixed for 35 min using the Silverson blender. At this stage the remaining quantity of water (16.5 kg) required to adjust the water content of the final bulk was added. The combined bulk homogenate (150 kg) was mixed for a further 60 min using the Silverson blender, stopping intermittently to remove any byssus threads that had collected on the mixing head.
Packaging and shipment to IRMM
The bulk homogenate was divided as 2.5 kg portions into 3 L containers. Throughout this process the remaining tissues in the drum were intermittently mixed until all the material had been sub-divided. The individual 2.5 kg portions were carefully sealed, frozen at -20°C, and then shipped to the Insitute for Reference Materials and Measurements (IRMM) in polystyrene boxes on a pallet using an overnight courier.
Freeze-drying, processing and bottling of wet homogenate (IRMM).
Freeze-drying
Thawing of the wet homogenate had just commenced when the raw material arrived at IRMM. The material was split into four batches for freeze-drying. The contents were poured into a plastic drum, rinsing each with approximately 100 mL of de-ionised water to recover all material. The slurry was manually homogenized using a Teflon paddle and subsequently transferred to flat-bottomed freeze-drying trays (30  45 cm), which were then placed in a pre-cooled freeze-drier Epsilon 2-85D (Martin-Christ, Osterode, Germany). Three Pt100 sensors and one lyo-control sensor were placed in the homogenate in trays positioned in the top, in the middle, and in the bottom of the drying chamber. An established 4 day freeze-drying program [33] was started with the following sequence of events: freezing, sublimation, and secondary drying. The water content of each batch was checked by Karl Fisher titration (KFT) (Metrohm, Herisau, Switzerland) after freeze-drying cycle to determine completion of the process (Supporting Information, Table 1 .). Values varied between 2.8 and 4.7% and were acceptable as the samples were taken prior to powder homogenization.
Crushing, milling sieving and homogenization
Dried batches were kept in sealed stainless steel drums at -20°C until completion of the four freeze-drying cycles. The dried material was pre-crushed in the drums to a fine powder using a heavy Teflon pestle. The drums were then placed in liquid nitrogen for pre-freezing and the powder was cryogenically milled using a PALLA VM-KT vibrating mill (KHD HumboldtWedag, Köln, Germany) in the temperature range -100 °C to -196 °C. Immediately after milling the particle size distributions of the batches were determined by laser diffraction using Sympatec Helos equipment (Clausthal-Zellerfeld, Germany) (method accredited at IRMM under ISO 17025).
Each batch was sieved (Russel Finex Industrial Sieve, London, UK) through a 250 µm stainless steel mesh, with steel-rings placed on the mesh to break agglomerates. Yields >95% were achieved with only non-tissue particles of sand and silt remaining on the sieve.
Batches were pooled and homogenized in a screw-capped drum using a T-200 Turbula mixer (WAB, Turbula, Basel, Switzerland) for 30 min. The material was divided in 20 portions and thermally sealed in polyethylene bags for ease of handling during bottling.
Bottle filling, capping and labelling
A filling machine (All-Fill International Ltd., Sandy, Bedfordshire, UK) was set up to dispense the powder into 30 mL amber glass vials. The glove-box surrounding the filling machine was purged with nitrogen. Lyophilisation inserts were automatically pressed down into the necks of the vials after filling to preserve an inert atmosphere inside the containers.
Bottles were capping and labelled in fill order using assemblies from Bausch & Ströbel (Ilshofen, Germany) and BBK (Beerfelden, Germany), respectively. The capping machine was operated at 10 vials per minute with manual loading and unloading of vials.
Analytical production control by water content and particle size analysis
A Luminar 4030 Acousto-Optical Tunable Filter Near Infrared Spectrometer (AOTF-NIR, Brimrose, MD, USA) was installed on the capping machine. This recorded 100 NIR spectra for each bottle, and the data was then evaluated and calibrated with a partial least squares model [42] . As a final production control, 12 bottles of the product were selected over the entire fill series to measure water content by KFT.
On the same 12 units selected for KFT, the particle size distribution was analysed using the Sympatec Helos laser diffraction instrument. The powder was loaded in a 50 mL cuvette with isopropanol and a diffraction measurement was performed for 10 sec. Each unit was measured twice (i.e. two separate loadings per bottle).
Finally, micrographs of the material were obtained using a 100 µm scale (certified length).
Storage at IRMM and preliminary toxin analysis
The stock material was retained at the IRMM (-20°C) until appropriate conditions of transport and storage were verified from stability studies. Some bottles of CRM-FDMT1 were also shipped chilled to the Marine Institute for a preliminary toxin analysis of the material. Extraction and instrumental methods described for stock tissues materials were used. The freeze-dried powder was reconstituted for extraction following the method reported previously [33] 3. Results and discussions
Characterisation of consituent materials
While it would not be practical to have every known toxin present in the material, a minimum requirement was that the material would contain a representative analog from each of the EU regulated classes of lipophilic compounds (OA/DTXs, AZAs, PTXs, YTXs) [43] . The various mussel tissues used were identified through regulatory and post-processing monitoring programs to be suitable for combination in a candidate CRM as they would contribute to a comprehensive and appropriate toxin profile. Water content and toxin concentrations for each of the individually processed tissue materials are given in Table 1 . The majority of the mussel materials required for the OA and AZA groups were obtained from toxin events that occurred in Ireland. However, DTX1 is typically only found at trace levels in Irish shellfish [44] so mussels harvested in Norway were obtained containing levels of DTX1 close to the regulatory limit. Hepatopancreas tissues were dissected in order to increase the concentration added, although this still required a considerable quantity of material. It was decided to also incorporate DA in the CRM as this hydrophilic toxin is often included in multi-toxin monitoring procedures for screening purposes [13, 14] . The mussels harvested in Prince Edward Island were implicated in the initial amnesic shellfish poisoning episode [22] and contained DA at a concentration almost 30 times the EU regulatory limit. As all the tissues had been cooked or thermally treated during processing, the water contents were lower than what would typically be expected for fresh tissues.
A number of toxins were obtained from non-shellfish tissue sources. The Dinophysis spp. extract contained approximately 15 mg of PTX2. Because this extract was only partially purified there were significant concentrations of OA and DTX1 also present (approximately 2.6 and 10.9 mg respectively). SPXs were included in the candidate CRM as a nonregulated lipophilic toxin class. Analysis of the Alexandrium ostenfeldii biomass gave an indicative total quantity of approximately 50 mg of 13-desMe-SPX-C. Based on quantitation at AgResearch there was a total of 58 mg of YTX in the dried YTX residues.
Combination of tissues and preparation of bulk wet homogenate (marine Institute)
The most important consideration in the design process was to have a toxin profile and toxin concentrations that would be relevant for end users of the material, i.e. regulated toxins represented at concentrations near the regulatory limits. A further aim was to be able to certify as many of the analytes in the candidate CRM as possible, while avoiding excessive uncertainties for the certified values. Therefore, it was desirable not to have too many analytes present at impedingly low levels. However, these types of natural products are extremely rare and valuable, so a limiting factor in some instances was the low concentrations present in the contaminated mussel materials available.
Based on the information obtained for the different materials (Table 1 ) a combination of tissues and toxin materials was prepared using the quantities outlined in Table 2 . Due to the high level of DA present in material A, a relatively small proportion of this tissue was needed to have a concentration in the final bulk wet homogenate approximately at the EU regulatory level. All the dissected Norwegian hepatopancreas (material B) was included in the mix to provide a base level concentration for DTX1, although this contribution was still relatively low. In order to maintain an overall whole flesh profile in the CRM, remainder tissues from Castletownbere (material C) were used to counter balance the large amount of Norwegian hepatopancreas. Material C contained OA, DTX2 and AZAs at levels sufficient to maintain a desirable profile for these toxins, while the quantity of tissue added did not significantly dilute concentrations of the other analytes in the material. The major contributor for AZAs was the Bruckless tissues (material D), which also contained OA. The Ardgroom tissue (material E) was added in the most significant quantity. This was primarily contaminated with OA and DTX2, and a benefit of this tissue was that it also contained high levels of OA and DTX2 esters, adding to the diversity of the toxin profile in the material. In the initial homogenisation stages the non-tissue materials were added, along with stabilising additives. The additives were included to prolong stability of the wet homogenate in the event of delays when shipping the bulk to the IRMM for freeze-drying. Although this was based on the findings of previous work [31] , no information is available on their stabilizing properties for phycotoxins RMs in combination with freeze-drying. In addition to providing a PTX2 spike for the CRM, the Dinophysis spp. extract also contained significant levels of OA and DTX1. This was particularly beneficial for DTX1 as material B only provided a low concentration of this analyte.
A final consideration was adjustment of moisture content. Although the homogenate was to undergo freeze-drying to produce a powder RM, previous feasibility studies indicated that for efficient freeze-drying of this matrix it is desirable to have sufficiently adjusted moisture content in the initial wet material [H. Emteborg, IRMM, pers comm]. Based on moisture content determinations of the individual tissues (Table 1 ) a combination of the quantities outlined would result in a combined material with a water content of 80.8%. This was adjusted to approx. 85% during the homogenisation. The process leading to the production of the bulk homogenate is schematically represented in Fig. 2 . Based on concentrations determined for the individual tissue materials (Table 1 ) and the amounts of the various materials used (Table 2) , indicative concentrations of the major toxins present in the bulk wet homogenate are shown at the bottom of Table 2 (as mg/kg of wet tissue).
Freeze-drying and physical characterisation of material (IRMM)
The production and characterisation process of the freeze-dried powder is schematically summarized in Fig 3. A total of 6918 units were filled with slightly more than 3 g in each. The bottle label included the material name (NRC CRM-FDMT1), a brief description of the material (Multi-toxin Mussel Tissue CRM), lot and sample numbers, a short safety precaution (not suitable for human consumption), and institute logos of the project collaborators. Once the bottles were capped and labelled they were placed in storage at -20°C. As part of the post-production process, a series of physical characterisation studies were carried out. An important parameter for freeze-dried materials is water content. In freeze-drying the main aim is to have a sufficiently low water content to inhibit microbiological activity, but it is also necessary to avoid decreasing the moisture level too much as this would lead to the material becoming hygroscopic. The moisture contents of each bottle were determined by AOTF-NIR during bottling (m/m 2.9%, ± 0.3, n=6918) showing no trends. This indicated highly reproducible filling conditions ( Supporting Information, Fig. 1 ). For a higher degree of accuracy and precision, 12 bottles of CRM-FDMT1 were selected over the entire fill series and moisture contents were determined using a fully validated KFT method (m/m 3.9%, ± 0.6, n=12, expanded uncertainty k=2). Although there is a slight systematic difference between the KFT and the AOFT-NIR values, the results are in reasonable agreement. Water content in the range of 3 to 4%, as achieved here, is rather optimal for dry biological powders with respect to matrix stability, as at this level there should be a low risk of bacterial growth or chemical reactions [45] .
Particle size information is important when considering the minimum sample intake of a powder, as this influences the uncertainty of the result obtained. Additionally, particle size analysis is a good indication of the effectiveness of the processing procedure, particularly the milling and sieving steps. Analysis of CRM-FDMT1 showed that the average particle size was approximately 50 µm (Fig. 4) , and was similar to that obtained in the previous feasibility study [33] . The cumulative distribution shows that 90% of particles are smaller than 120 µm (Table 3) corresponding to the very high yield from the sieving through the 250-µm mesh. The relative standard deviations between the different units is around 5% for the size classes from X 16 and upwards, confirming particle size uniformity over the whole production batch.
Micrographs are a valuable complement to particle size distribution measurements as they can reveal colour differences, fractionations due to particle shape, and they provide a visual indication of particle size based on direct comparison with a certified length scale. From the micrographs of CRM-FDMT1 it was observed that particles of the final bottled material were indeed generally below 100 µm ( Supplementary Information, Fig. 2 ).
Preliminary analysis of CRM-FDMT1
To give a preliminary overview of the CRM toxin profile, concentrations of the regulated analogues relative to the EU regulatory levels are shown (Fig. 5) . It can be seen that CRM-FDMT1 has a comprehensive toxin profile, with some analytes present at concentrations above and some below the regulatory level. These values are only considered indicative as the extraction procedures had not been fully optimised for complete recovery of the different toxins, no assessment of matrix effects was made for the LC-MS analysis, and calibrant CRMs were not available at this stage for each toxin analog present. In addition to the toxins represented in Fig. 5 , the candidate CRM contains a variety of other analogs and isomers from the toxin groups present.
Conclusions
A candidate CRM for multiple groups of shellfish toxins has been prepared. Extensive effort was put into arrangement of the project, collection, collation, processing, purification and characterisation of the individual toxin materials, preparation of a bulk wet homogenate, and ultimately freeze-drying, processing and bottling of the candidate CRM. Almost 7000 units were produced, each containing approximately 3 g of freeze-dried powder. In regulatory analysis of shellfish toxins, freeze-dried matrices are not typically analysed, however, they are less susceptible to degradation and are therefore more efficient for ensuring the longterm stability required of a CRM. The CRMs representativeness of 'real-life' samples concedes to the various processes and treatments that are carried out during preparation of the material to ensure that it is fit for purpose (homogeneous and stable) over the necessary periods of time. However, the difference in the CRM-FDMT1 matrix should not present a major problem to analysts as it is accepted that natural samples routinely vary in composition and the analytical methods used must be robust enough to deal with these variations.
Analytical process control of the bottled freeze-dried product showed that water content, particle size, and particle size distribution, were all appropriate. Table 3 . Average particle size, absolute and relative standard deviations for the predefined cumulative distributions X 0 (upper band limit) for n = 12 of CRM-FDMT1. Toxin and moisture content analysis
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